These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17611692)

  • 1. Auristatin PYE, a novel synthetic derivative of dolastatin 10, is highly effective in human colon tumour models.
    Shnyder SD; Cooper PA; Millington NJ; Pettit GR; Bibby MC
    Int J Oncol; 2007 Aug; 31(2):353-60. PubMed ID: 17611692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the activity of cisplatin in a human colon tumour xenograft model by auristatin PYE, a structural modification of dolastatin 10.
    Prokopiou EM; Cooper PA; Pettit GR; Bibby MC; Shnyder SD
    Mol Med Rep; 2010; 3(2):309-13. PubMed ID: 21472238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
    Mohammad RM; Varterasian ML; Almatchy VP; Hannoudi GN; Pettit GR; Al-Katib A
    Clin Cancer Res; 1998 May; 4(5):1337-43. PubMed ID: 9607595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126.
    Cullis ER; Kalber TL; Ashton SE; Cartwright JE; Griffiths JR; Ryan AJ; Robinson SP
    Microvasc Res; 2006 Mar; 71(2):76-84. PubMed ID: 16530791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum.
    Fennell BJ; Carolan S; Pettit GR; Bell A
    J Antimicrob Chemother; 2003 Apr; 51(4):833-41. PubMed ID: 12654761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A natural peptide, dolastatin 15, induces G2/M cell cycle arrest and apoptosis of human multiple myeloma cells.
    Sato M; Sagawa M; Nakazato T; Ikeda Y; Kizaki M
    Int J Oncol; 2007 Jun; 30(6):1453-9. PubMed ID: 17487366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor and anti-vascular effects of the novel tubulin-binding agent combretastatin A-1 phosphate.
    Holwell SE; Cooper PA; Thompson MJ; Pettit GR; Lippert LW; Martin SW; Bibby MC
    Anticancer Res; 2002; 22(6C):3933-40. PubMed ID: 12553015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor effects of TZT-1027, a novel dolastatin 10 derivative, on human tumor xenografts in nude mice].
    Fujita F; Koike M; Fujita M; Sakamoto Y; Tsukagoshi S
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):451-8. PubMed ID: 10740640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay.
    Aherne GW; Hardcastle A; Valenti M; Bryant A; Rogers P; Pettit GR; Srirangam JK; Kelland LR
    Cancer Chemother Pharmacol; 1996; 38(3):225-32. PubMed ID: 8646796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tirapazamine causes vascular dysfunction in HCT-116 tumour xenografts.
    Huxham LA; Kyle AH; Baker JH; McNicol KL; Minchinton AI
    Radiother Oncol; 2006 Feb; 78(2):138-45. PubMed ID: 16455148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of 3,5,4'-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice.
    Pan MH; Gao JH; Lai CS; Wang YJ; Chen WM; Lo CY; Wang M; Dushenkov S; Ho CT
    Mol Carcinog; 2008 Mar; 47(3):184-96. PubMed ID: 18085528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of selected natural products as therapeutic agents against cancer.
    Banerjee S; Wang Z; Mohammad M; Sarkar FH; Mohammad RM
    J Nat Prod; 2008 Mar; 71(3):492-6. PubMed ID: 18302335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
    Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY
    J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug.
    Grosios K; Holwell SE; McGown AT; Pettit GR; Bibby MC
    Br J Cancer; 1999 Dec; 81(8):1318-27. PubMed ID: 10604728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB; Zhou JH; Zuo MX; You QD
    Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice.
    Gil-Ad I; Zolokov A; Lomnitski L; Taler M; Bar M; Luria D; Ram E; Weizman A
    Int J Oncol; 2008 Aug; 33(2):277-86. PubMed ID: 18636148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combretastatin A-1 phosphate a novel tubulin-binding agent with in vivo anti vascular effects in experimental tumours.
    Holwell SE; Cooper PA; Grosios K; Lippert JW; Pettit GR; Shnyder SD; Bibby MC
    Anticancer Res; 2002; 22(2A):707-11. PubMed ID: 12017147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacology of the natural marine product dolastatin 10 (NSC 376128).
    Newman RA; Fuentes A; Covey JM; Benvenuto JA
    Drug Metab Dispos; 1994; 22(3):428-32. PubMed ID: 8070319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.